Very Low Density Lipoprotein (VLDL) Antikörper
VLDL
Reaktivität: Human
WB, EIA, IP
Wirt: Kaninchen
Polyclonal
unconjugated
-
-
Target
Alle Very Low Density Lipoprotein (VLDL) Antikörper anzeigen
-
Very Low Density Lipoprotein (VLDL)
-
Reaktivität
-
Human
-
Wirt
-
Kaninchen
-
Klonalität
-
Polyklonal
-
Konjugat
-
Unkonjugiert
-
Applikation
-
Western Blotting (WB), Enzyme Immunoassay (EIA), Immunoprecipitation (IP)
-
Verwendungszweck
-
Rabbit polyclonal antibody raised against native VLDL.
-
Kreuzreaktivität
-
Human
-
Produktmerkmale
-
Antibody Reactive Against Native Protein.
-
Immunogen
-
Native purified human very low density lipoproteins.
-
Isotyp
-
IgG
-
Top Product
-
Discover our top product VLDL Primärantikörper
-
-
-
Applikationshinweise
-
The optimal working dilution should be determined by the end user.
-
Beschränkungen
-
Nur für Forschungszwecke einsetzbar
-
-
Format
-
Liquid
-
Buffer
-
In PBS, pH 7.5 (50 % glycerol, 0.01 % thimerosal)
-
Konservierungsmittel
-
Thimerosal (Merthiolate)
-
Vorsichtsmaßnahmen
-
This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
-
-20 °C
-
Informationen zur Lagerung
-
Store at -20°C.
Aliquot to avoid repeated freezing and thawing.
-
-
Target
-
Very Low Density Lipoprotein (VLDL)
-
Andere Bezeichnung
-
VLDL (VLDL Produkte)
-
Synonyme
-
425O18-1 antikoerper, 8D6 antikoerper, D17Ertd716e antikoerper, NG29 antikoerper, VLDL antikoerper, CD320 antigen antikoerper, Cd320 antikoerper
-